Your browser is no longer supported. Please, upgrade your browser.
Settings
GILD [NASD]
Gilead Sciences, Inc.
IndexS&P 500 P/E11.90 EPS (ttm)5.84 Insider Own0.10% Shs Outstand1.26B Perf Week-1.01%
Market Cap86.11B Forward P/E10.30 EPS next Y6.76 Insider Trans-1.14% Shs Float1.25B Perf Month3.19%
Income7.39B PEG8.98 EPS next Q1.95 Inst Own82.70% Short Float1.84% Perf Quarter-3.34%
Sales27.48B P/S3.13 EPS this Y-97.70% Inst Trans1.41% Short Ratio3.38 Perf Half Y3.17%
Book/sh17.09 P/B4.07 EPS next Y-16.64% ROA10.90% Target Price76.45 Perf Year14.30%
Cash/sh4.64 P/C15.01 EPS next 5Y1.32% ROE37.80% 52W Range56.56 - 73.34 Perf YTD19.40%
Dividend2.84 P/FCF14.54 EPS past 5Y-61.80% ROI5.00% 52W High-5.15% Beta0.37
Dividend %4.08% Quick Ratio1.20 Sales past 5Y-5.40% Gross Margin80.50% 52W Low22.98% ATR1.35
Employees13600 Current Ratio1.40 Sales Q/Q12.80% Oper. Margin42.30% RSI (14)56.61 Volatility2.13% 1.78%
OptionableYes Debt/Eq1.29 EPS Q/Q619.40% Profit Margin26.90% Rel Volume1.20 Prev Close69.67
ShortableYes LT Debt/Eq1.17 EarningsOct 28 AMC Payout47.70% Avg Volume6.84M Price69.56
Recom2.40 SMA201.97% SMA502.25% SMA2002.79% Volume8,206,614 Change-0.16%
Nov-19-21Upgrade BMO Capital Markets Market Perform → Outperform $72 → $85
Nov-19-21Resumed Piper Sandler Neutral $77
Oct-20-21Resumed Cowen Outperform
Jul-30-21Reiterated RBC Capital Mkts Outperform $81 → $84
Jul-30-21Reiterated BMO Capital Markets Market Perform $67 → $72
Apr-01-21Upgrade Bernstein Mkt Perform → Outperform $80
Mar-30-21Upgrade Redburn Neutral → Buy
Jan-19-21Upgrade Morgan Stanley Equal-Weight → Overweight $83
Jan-04-21Upgrade Guggenheim Neutral → Buy
Nov-03-20Resumed Morgan Stanley Equal-Weight $67
Oct-28-20Initiated UBS Neutral $61
Sep-30-20Resumed Jefferies Buy $78
Sep-15-20Upgrade Maxim Group Hold → Buy $88
Jul-31-20Reiterated Wells Fargo Equal Weight $87 → $76
Jul-31-20Reiterated SunTrust Hold $73 → $74
Jul-31-20Reiterated RBC Capital Mkts Outperform $89 → $87
Jul-31-20Reiterated Piper Sandler Overweight $90 → $85
Jul-31-20Reiterated Morgan Stanley Equal-Weight $80 → $79
Jul-31-20Reiterated Credit Suisse Neutral $75 → $73
Jul-20-20Upgrade Credit Suisse Underperform → Neutral $64 → $75
Dec-03-21 06:15AM  
Dec-01-21 08:11AM  
Nov-30-21 09:15AM  
08:56AM  
08:11AM  
Nov-29-21 05:56PM  
08:30AM  
Nov-26-21 08:46AM  
Nov-25-21 07:28AM  
Nov-24-21 05:33PM  
04:55PM  
11:21AM  
10:31AM  
Nov-23-21 10:01AM  
08:30AM  
Nov-22-21 04:20PM  
10:48AM  
Nov-19-21 12:36PM  
09:43AM  
08:00AM  
Nov-18-21 04:18PM  
04:05PM  
09:53AM  
09:11AM  
08:44AM  
07:38AM  
07:00AM  
Nov-16-21 10:02AM  
Nov-15-21 10:00AM  
Nov-12-21 06:01PM  
12:56PM  
10:56AM  
Nov-11-21 10:15AM  
Nov-10-21 07:00PM  
Nov-09-21 01:01PM  
10:00AM  
Nov-08-21 02:41PM  
Nov-04-21 09:23AM  
Nov-03-21 05:35PM  
03:25PM  
05:30AM  
Nov-02-21 04:01PM  
01:26PM  
Nov-01-21 05:16PM  
04:05PM  
Oct-29-21 04:19PM  
02:33PM  
11:31AM  
08:24AM  
08:09AM  
07:30AM  
06:16AM  
Oct-28-21 05:25PM  
04:51PM  
04:22PM  
04:19PM  
04:10PM  
04:02PM  
02:21PM  
Oct-27-21 11:10AM  
11:10AM  
10:00AM  
08:34AM  
Oct-26-21 10:46AM  
06:45AM  
Oct-25-21 10:09AM  
08:50AM  
Oct-23-21 11:30AM  
11:00AM  
Oct-22-21 05:50PM  
03:01PM  
Oct-21-21 03:02PM  
07:37AM  
Oct-20-21 02:39PM  
Oct-19-21 04:46PM  
09:38AM  
08:30AM  
Oct-18-21 10:45AM  
07:30AM  
Oct-15-21 02:14PM  
09:29AM  
08:00AM  
Oct-14-21 04:05PM  
02:37PM  
12:10PM  
08:03AM  
Oct-13-21 02:32PM  
10:52AM  
Oct-12-21 02:30PM  
12:06PM  
Oct-08-21 02:32PM  
05:36AM  
Oct-07-21 01:48PM  
Oct-06-21 02:32PM  
07:31AM  
06:18AM  
Oct-05-21 01:08PM  
09:46AM  
Oct-04-21 11:59AM  
10:13AM  
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of human immunodeficiency virus (HIV) infection; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr; Tizona; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos; Janssen; Japan Tobacco, Inc.; Gadeta; Bristol-Myers Squibb Company; Merck; and Novo Nordisk A/S. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilfong Diane E.SVP, Controller & CAOAug 17Option Exercise68.0813,610926,53634,008Aug 18 07:32 PM
Wilfong Diane E.SVP, Controller & CAOAug 17Sale72.5013,610986,72520,398Aug 18 07:32 PM
Mercier JohannaChief Commercial OfficerMay 04Sale66.0919,4961,288,5478,068May 05 05:02 PM
Whitley Richard JamesDirectorMay 03Option Exercise20.6420,282418,72251,404May 04 06:37 PM
Whitley Richard JamesDirectorMay 03Sale64.5720,2821,309,65531,122May 04 06:37 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselMar 11Sale63.361,48694,15329,166Mar 12 06:39 PM
Wilfong Diane E.SVP, Controller & CAOFeb 10Option Exercise0.00778017,606Feb 11 05:58 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 10Sale67.411,975133,13528,832Feb 11 05:56 PM
Wilfong Diane E.SVP, Controller & CAOFeb 06Option Exercise0.001,866017,361Feb 09 07:46 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 06Option Exercise0.002,728031,560Feb 09 07:44 PM
Dickinson Andrew DEVP, Chief Financial OfficerFeb 06Option Exercise0.001,818033,081Feb 09 07:41 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 01Sale65.979,711640,63328,832Feb 03 06:23 PM
Lofton Kevin EDirectorJan 22Option Exercise20.6420,282418,72274,203Jan 25 01:55 PM